Published online Aug 26, 2022. doi: 10.12998/wjcc.v10.i24.8679
Peer-review started: February 14, 2022
First decision: March 24, 2022
Revised: April 3, 2022
Accepted: July 25, 2022
Article in press: July 25, 2022
Published online: August 26, 2022
Processing time: 182 Days and 1.7 Hours
Lichen planus (LP) with distribution of lesions along Blaschko’s lines is a rare entity, accounting for 0.24%-0.62% of all patients. Unilateral distribution of lesions in arm, leg, trunk, and waist is even less common. Approximately 10% of patients with LP manifest nail lesions.
A 20-year-old woman presented to our department with polygonal, purpuric, flat-topped papules over the right arm, right leg, and right side of trunk and waist for the last 5 mo. The patient initially developed nail deformation in the left middle finger with no obvious cause, followed by development of blue-purple and red maculopapular rash with pruritus. During the disease course, the skin lesions aggravated and spread to several segments due to scratching. The lesions showed unilateral distribution along the Blaschko’s lines. The diagnosis of LP along Blaschko’s lines was established based on dermoscopy and skin biopsy. Her cutaneous lesions considerably improved after 4-wk treatment with intramuscular glucocorticoid, oral acitretin, topical glucocorticoid, and retinoids.
Cases of LP involving multiple segments of the body along the Blaschko’s lines with nail damage are rare.
Core Tip: Lichen planus (LP) with lesion distribution along the Blaschko’s lines can be differentiated from other skin lesions with linear distribution by dermoscopy and pathological biopsy. The isotopic response can occur in patients with LP, which may be an important cause for rapid spread of lesions and involvement of multiple segments. Therefore, early diagnosis and treatment are of great significance. Treatment strategy should be individualized based on the lesion characteristics and patient acceptance. Our patient showed considerable improvement of cutaneous lesions after 4-wk treatment with intramuscular glucocorticoid, oral acitretin, topical glucocorticoid and retinoids.